Literature DB >> 24175186

What is the purpose of launching the World Journal of Transplantation?

Maurizio Salvadori1.   

Abstract

Congratulations to the publisher, members of the editorial board of the journal, all the authors and readers for launching the World Journal of Transplantation (WJT) as a new member of the World series journal family. Transplantations are rapidly evolving and share knowledge with a number of basic and clinical sciences: molecular biology, stem cell investigators, immune system, pharmacology, biotechnology, surgery and physicians of different organs such as the kidneys, liver, heart, lung, bone marrow and so on. The WJT is a peer reviewed open access journal centered on the different fields involved in transplant activity. If you want to share your experiences and new findings in the field of transplantation with your peers you will find the WJT a good media to publish your papers.

Entities:  

Keywords:  Open access journal; Peer reviewed; Transplant related sciences; Transplantation

Year:  2011        PMID: 24175186      PMCID: PMC3782228          DOI: 10.5500/wjt.v1.i1.1

Source DB:  PubMed          Journal:  World J Transplant        ISSN: 2220-3230


  10 in total

1.  Lung assist device technology with physiologic blood flow developed on a tissue engineered scaffold platform.

Authors:  David M Hoganson; Howard I Pryor; Erik K Bassett; Ira D Spool; Joseph P Vacanti
Journal:  Lab Chip       Date:  2010-12-13       Impact factor: 6.799

2.  Identification of a potent Janus kinase 3 inhibitor with high selectivity within the Janus kinase family.

Authors:  Gebhard Thoma; Francois Nuninger; Rocco Falchetto; Erwin Hermes; Gisele A Tavares; Eric Vangrevelinghe; Hans-Günter Zerwes
Journal:  J Med Chem       Date:  2010-12-14       Impact factor: 7.446

3.  Liver-assist device with a microfluidics-based vascular bed in an animal model.

Authors:  Wen-Ming Hsu; Amedeo Carraro; Katherine M Kulig; Mark L Miller; Mohammad Kaazempur-Mofrad; Eli Weinberg; Fateh Entabi; Hassan Albadawi; Michael T Watkins; Jeffrey T Borenstein; Joseph P Vacanti; Craig Neville
Journal:  Ann Surg       Date:  2010-08       Impact factor: 12.969

4.  Islet transplantation in type 1 diabetic patients using calcineurin inhibitor-free immunosuppressive protocols based on T-cell adhesion or costimulation blockade.

Authors:  Andrew M Posselt; Gregory L Szot; Lynda A Frassetto; Umesh Masharani; Mehdi Tavakol; Raj Amin; Joan McElroy; Marissa D Ramos; Robert K Kerlan; Lawrence Fong; Flavio Vincenti; Jeffrey A Bluestone; Peter G Stock
Journal:  Transplantation       Date:  2010-12-27       Impact factor: 4.939

5.  Monocyte infiltration and kidney allograft dysfunction during acute rejection.

Authors:  R Girlanda; D E Kleiner; Z Duan; E A S Ford; E C Wright; R B Mannon; A D Kirk
Journal:  Am J Transplant       Date:  2008-03       Impact factor: 8.086

6.  Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart.

Authors:  Harald C Ott; Thomas S Matthiesen; Saik-Kia Goh; Lauren D Black; Stefan M Kren; Theoden I Netoff; Doris A Taylor
Journal:  Nat Med       Date:  2008-01-13       Impact factor: 53.440

7.  Normothermic ex vivo lung perfusion in clinical lung transplantation.

Authors:  Marcelo Cypel; Jonathan C Yeung; Mingyao Liu; Masaki Anraku; Fengshi Chen; Wojtek Karolak; Masaaki Sato; Jane Laratta; Sassan Azad; Mindy Madonik; Chung-Wai Chow; Cecilia Chaparro; Michael Hutcheon; Lianne G Singer; Arthur S Slutsky; Kazuhiro Yasufuku; Marc de Perrot; Andrew F Pierre; Thomas K Waddell; Shaf Keshavjee
Journal:  N Engl J Med       Date:  2011-04-14       Impact factor: 91.245

8.  Evidence for antibody-mediated injury as a major determinant of late kidney allograft failure.

Authors:  Robert S Gaston; J Michael Cecka; Bert L Kasiske; Ann M Fieberg; Robert Leduc; Fernando C Cosio; Sita Gourishankar; Joseph Grande; Philip Halloran; Lawrence Hunsicker; Roslyn Mannon; David Rush; Arthur J Matas
Journal:  Transplantation       Date:  2010-07-15       Impact factor: 4.939

Review 9.  Profile of belatacept and its potential role in prevention of graft rejection following renal transplantation.

Authors:  Gaurav Gupta; Karl L Womer
Journal:  Drug Des Devel Ther       Date:  2010-12-01       Impact factor: 4.162

10.  Role of natural killer cell subsets in cardiac allograft rejection.

Authors:  M E McNerney; K-M Lee; P Zhou; L Molinero; M Mashayekhi; D Guzior; H Sattar; S Kuppireddi; C-R Wang; V Kumar; M-L Alegre
Journal:  Am J Transplant       Date:  2006-03       Impact factor: 8.086

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.